Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

著者: David Planchard, Tae Min Kim, Julien Mazières, Élisabeth Quoix, Gregory J. Riely, Fabrice Barlési, Pierre‐Jean Souquet, Egbert F. Smit, Harry J.M. Groen, Ronan J. Kelly, Byoung Chul Cho, Mark A. Socinski, Lini Pandite, Christine Nase, Bo Ma, Anthony M. D’Amelio, Bijoyesh Mookerjee, C. Martin Curtis, Bruce E. Johnson - The Lancet 2016 被引用: 444